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Background: Biting midges of the genus Culicoides Latreille, 1809 (Diptera: Ceratopogonidae) cause a significant
biting nuisance to equines and are responsible for the biological transmission of African horse sickness virus (AHSV).
While currently restricted in distribution to sub-Saharan Africa, AHSV has a history of emergence into southern
Europe and causes one of the most lethal diseases of horses and other species of Equidae. In the event of an
outbreak of AHSV, the use of insecticide treated nets (ITNs) to screen equine accomodation is recommended by
competent authorities including the Office International des Épizooties (OIE) in order to reduce vector-host contact.
Methods: Seven commercially avaliable pyrethroid insecticides and three repellent compounds, all of which are
licensed for amateur use, were assessed in modified World Health Organization (WHO) cone bioassay trials in the
laboratory using a colony line of Culicoides nubeculosus (Meigen), 1830. Two field trials were subsequently
conducted to test the efficiency of treated net screens in preventing entry of Culicoides.
Results: A formulation of cypermethrin (0.15 % w/w) and pyrethrins (0.2 % w/w) (Tri-Tec 14®, LS Sales (Farnham)
Ltd, Bloxham, UK) applied to black polyvinyl-coated polyester insect screen (1.6 mm aperture; 1.6 mm thickness)
inflicted 100 % mortality on batches of C. nubeculosus following a three minute exposure in the WHO cone
bioassays at 1, 7 and 14 days post-treatment. Tri-Tec 14® outperformed all other treatments tested and was
subsequently selected for use in field trials. The first trial demonstrated that treated screens placed around an
ultraviolet light-suction trap entirely prevented Culicoides being collected, despite their collection in identical traps
with untreated screening or no screening. The second field trial examined entry of Culicoides into stables
containing horses and found that while the insecticide treated screens reduced entry substantially, there was still a
small risk of exposure to biting.
Conclusions: Screened stables can be utilised as part of an integrated control program in the event of an AHSV
outbreak in order to reduce vector-host contact and may also be applicable to protection of horses from Culicoides
during transport.
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Biting midges of the genus Culicoides Latreille, 1809
(Diptera: Ceratopogonidae) cause biting nuisance to
humans, livestock and equines [1]. Hypersensitivity reac-
tion to the bites of Culicoides are the primary cause of
equine summer seasonal recurrent allergic dermatitis [2],
commonly known as ‘sweet-itch’. This condition affects
between 2 and 12 % of horses in the UK [2–5], although
studies from other countries in northern Europe indicates
that this prevalence may be underestimated [6]. Culicoides
also act as the biological vectors of arboviruses, including
African horse sickness virus (AHSV), which effects all
Equidae and causes devastating outbreaks of the disease
African horse sickness (AHS) (reviewed by [7, 8]). Mortality
rates in horses, mules and European and Asian donkeys
can reach 95, 50 and 10 % respectively in susceptible
populations dependent upon the form of the clinical
manifestation of the disease (in ascending order of severity:
the subclinical form (horse sickness fever), the subacute/
cardiac form, the mixed (cardiac and pulmonary form) and
the acute respiratory/pulmonary form), while zebra and
African donkeys rarely exhibit clinical signs [7]. While
currently restricted to sub-Saharan Africa, AHSV has long
been recognised as a threat to the equine industry in
Europe due to historical incursions of the virus in 1966
(Spain) and in 1987–1991 (Spain and Portugal) [9, 10].
Recent outbreaks of bluetongue virus (BTV), a related
Culicoides-borne arbovirus of ruminants has heightened
this awareness and led to dedicated risk assessments,
contingency planning and legislation for the incursion and
spread of AHSV [11–13]. A large-scale epidemic of AHSV
in the UK could potentially cost the equine industry up to
£3.5 billion and the traumatic nature of the disease would
also be expected to have a severe social impact [14].
While vaccines for AHSV are available [15], none are
currently licenced for use within the UK or European
Union (EU), where AHSV is currently absent but is
compulsorily notifiable. Although available vaccines
may be granted licences for emergency use in the event
of an AHSV incursion into Europe, in their absence, a
combination of effective vector control measures and
animal movement restrictions is the only currently
available means of reducing AHSV spread following
incursion [16]. While these measures were notably
unsuccessful in controlling BTV outbreaks in northern
Europe during the epidemic of BTV-8 (2006–9) [17],
the fewer available hosts for AHSV in the region may
improve the potential for techniques to reduce vector-host
contact rates and mitigate against virus transmission.
Among the methods used to control Culicoides
populations worldwide (reviewed by [7, 16, 18]),
housing of horses during periods of peak biting
activity has long been anecdotally observed to act as
a protective measure against AHS [19]. The successof this method in reducing ASHV transmission in
the Republic of South Africa (RSA) is attributed to
the strong exophilic nature of the principle AHSV
vector in the region, C. imicola Kieffer, 1913 [20]. In
more high-lying regions of RSA, however, the presence
of the endophilic species C. bolitinos Meiswinkel, 1989
sustains AHSV transmission even when horses are
stabled, although the number of Culicoides collected
were substantially reduced by screening [20].
In northern Europe, members of the subgenus
Avaritia (which in the UK includes: C. obsoletus
(Meigen), 1818; C. scoticus Downes and Kettle, 1952;
C. dewulfi (Goetghebuer), 1936; and C. chiopterus
(Meigen), 1830) are the most likely vectors of BTV
[21, 22] and the recently identified Schmallenberg
virus (SBV) [23]. In addition, isolations of AHSV
were also made from pools of species including C.
obsoletus and/or C. scoticus in Cadiz, Spain during
the epidemic in 1988 [24]. While primarily exophilic,
these species are thought to exhibit seasonably variable
levels of endophilic behaviour [25–27]. This indicates
that additional measures may be required to protect
stabled horses from vector contact [28, 29].
The creation of truly vector-proof accommodation is
rarely attempted due to the costs involved and the
difficulties in accurately monitoring potential lapses in
biosecurity. The creation or modification of equine accom-
modation to reduce vector-host contact, however, may be
achievable if wide-scale stockholder uptake is required in
the event of an AHSV outbreak. It is currently recom-
mended by competent authorities that in the event of
an AHSV incursion, stables and horse transport should
be screened with netting treated with an insecticide
with a residual effect [30, 31]. There are, however, no
insecticidal products currently authorised specifically
against Culicoides in the EU [32]. In addition, no quan-
titative data is available regarding the effect of available
insecticides in reducing vector-host contact, or on the
logistical feasibility of their use.
A current key concern is that changes in health and
safety and environmental legislation for the use of
insecticides in the UK and the EU have resulted in
insecticides previously recommended for use against
Culicoides no longer being licenced [18]. In addition,
other insecticides are now only available for use by
those holding a current Certificate of Competence in
the use of pesticides [33, 34], something the majority
of UK horse owners are unlikely to hold. This study
therefore aims to investigate the effectiveness of
mesh netting suitable for screening stables treated
with commercially available pyrethroid insecticides
licenced by the UK Health and Safety Executive
(HSE) for ‘amateur use’ for reducing vector-host
contact.
Fig. 1 Black polyvinyl-coated polyester used during studies. Image
taken and calibrated using a QICAM Fast 1394 digital camera (QImaging,
Surrey, BC, Canada) and Image-Pro Insight (MediaCybernetics, Rockville,
MD, USA) mounted on a Leica M80 stereo light microscope (Leica
Microsystems, Milton Keynes, UK)
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Insecticides and screening
The UK HSE Control of Pesticides Regulation database
[35] and manufactures’ information was screened to select
insecticides which matched the following criteria: (i) con-
tains at least one pyrethroid as an active ingredient, (ii) are
licenced for ‘amateur use’, (iii) are currently commercially
available in the UK, (iv) are marketed as being capable of
being used to treat surfaces/buildings for the reduction of
flying insects and (v) in order to be financially viable for the
treatment of large surface areas available in quantities of
2 L or greater. This resulted in the selection of seven in-
secticidal treatments (Table 1). In addition, three repellents
representative of the compounds commonly used in the
UK equine market (Harrup et al., unpublished data) were
selected for comparison (Table 1). PetMesh insect screen
(Fine Mesh Metals, Telford, UK) black polyvinyl-coated
polyester (1.6 mm aperture; 1.6 mm thickness) (Fig. 1) was
used for all experiments.
WHO cone bioassays
Initial screening of insecticide efficacy was conducted using
colony derived Culicoides nubeculosus (Meigen), 1830 from
the Pirbright line [36] and modified World Health
Organization (WHO) cone bioassays (Fig. 1). Sections of
mesh netting (10 cm× 30 cm) were individually treated
with each of the selected insecticides/repellents on day 0
(one mesh section per insecticide/repellent). Each mesh
section was sprayed for 10s (5 s per side) with the selected
insecticide/repellent dispensed from a 1.5 L hand-held
pump sprayers (Pest Control Shop, Preston, UK). In
addition, each mesh section was weighed pre- and post-
treatment using a portable balance (SPU123: OhausTable 1 World Health Organisation (WHO) Cone Bioassays: Treatme
Treatment Type Treatment name (Supplier)
A Insecticide Agropharm’s Dairy Fly Spray (Agropharm Ltd, Penn,
B Insecticide Degrain Insectaclear C (Lodi UK, Kingswinform, UK)
C Insecticide Fly Free Zone (Fly Away Ltd, Stourbridge, UK)
D Insecticide Protector C (Agropharm Ltd, Penn, UK)
E Insecticide Strikeback Insect Killing Spray (Group 55, Preston, UK
F Insecticide Tri-Tec 14® (LS Sales (Farnham) Ltd, Bloxham, UK)
G Insecticide Ultrashield EX (W.F. Young, Inc, East Longmeadow, M
H Repellent NAF Off Citronella (Greencoat Ltd t/a Natural Animal
I Repellent NAF Off DEET POWER (Greencoat Ltd t/a Natural An
UK)
J Repellent NAF Off Extra Effect (Greencoat Ltd t/a Natural Anim
UK)
K - Untreated Mesh
L - Untreated Filter Paper
aalso contains Piperonylbutoxide [5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1-3-Corporation, NJ, USA) and the weight of insecticide
applied calculated in order to estimate the amount of
active ingredient applied (Table 2). Following treatment all
treated mesh sections in addition to an untreated mesh
section were hung undercover outdoors for 24 h prior to
any exposure assays being conducted to allow the treat-
ments to dry. Mesh sections were hung at least 30 cm
apart to prevent cross-contamination and protected from
direct sunlight and rainfall, but the cover was open on all
four sides allowing mesh sections to be exposed to the
prevailing weather conditions. Treatment of mesh sections
was conducted by LEH, followed by blinding andnts compared using modified WHO Cone Bioassays
Active ingredient
UK) Pyrethrins including cinerins 0.25 % w/w a
Cypermethrin 0.1 % w/w
Permethrin 0.1 % w/w; Tetramethrin 0.04 % w/
w
Cypermethrin 0.09 % w/w
) Cypermethrin 0.01 % w/w
Cypermethrin 0.15 % w/w; Pyrethrins 0.2 % w/
w a
A, USA) Permethrin 0.5 % w/w; Pyrethrins 0.1 % w/w a
Feeds, Monmouth, UK) Citronella Oil <1.5 % w/w
imal Feeds, Monmouth, DEET <20 % w/w
al Feeds,Monmouth, Citriodiol1% w/w
benzodioxole as a synergist
Table 2 World Health Organisation (WHO) Cone Bioassays: Mean estimated application rate of active ingredients in mg/cm2 of
selected insecticide/repellent-based treatments, range between treatment batches shown in parenthesis
Treatment Active Ingredient (mg/cm2)
Citriodiol Citronella Oil Cypermethrin DEET Permethrin Pyrethrins Tetramethrin
Aa - - - - - 2.8 (2.2–3.3) -
B - - 1.2 (1.1–1.4) - - - -
C - - - - 1.2 (1.1–1.4) - 0.5 (0.4–0.6)
D - - 1.0 (0.9–1.1) - - - -
E - - 0.1 (0.1–0.1) - - - -
Fa - - 2.7 (2.0–3.0) - - 3.1 (2.3–3.4) -
Ga - - - - 6.8 (6.6–7.2) 1.3 (1.3–1.4) -
H - 22.1 (19.0–27.5) - - - - -
I - - - 292.2 (215.1–366.6) - - -
J 12.5 (10.6–14.7) - - - - - -
− not an active ingredient in treatment
aalso contains Piperonylbutoxide [5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1-3-benzodioxole as a synergist) (Treatments K and L untreated negative controls
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experiments were conducted by LEH.
At 24 h (day 1), seven days (day 7) and 14 days
(day 14) post-treatment mesh sections were secured
between 10 cm by 30 cm white translucent plastic
boards (Challoner Marketing Ltd, Amersham, UK)
and two WHO bioassay cones (Vector Control Research
Unit, UniversitiSains Malaysia, Malaysia) were prepared for
each mesh section (Fig. 2). Twenty-five three to four day-
old non-bloodfed female C. nubeculosus, which had had
access to cotton wool soaked in a 10 % sucrose solution for
the previous 24 h were introduced to each bioassay cone.
The entrance port to each WHO bioassay cone was then
sealed with a 25 mm polyurethane white foam stopper
(Fisher Scientific, UK) (Fig. 2). After a three minuteFig. 2 World Health Organization (WHO) cone bioassays exposure
equipment. Treated or untreated mesh net sections secured between
10 cm by 30 cm white translucent plastic board (Challoner Marketing
Ltd, Amersham, UK) and two WHO bioassay cones (Vector Control
Research Unit, UniversitiSains Malaysia, Malaysia) into which twenty-five
three to four day-old non-bloodfed female C. nubeculosus were
introduced per bioassay cone for a three minute exposure periodexposure period, Culicoides were removed from the bio-
assay cone using a manual aspirator fitted with an in-line
HEPA-filter (GE Healthcare Life Sciences, UK) and trans-
ferred to an 8 cm round cardboard pill pot (Watkins and
Doncaster, UK) covered with fine white nylon mesh
(160 μm aperture) (MegaView Science Co. Ltd, Taiwan).
The above protocol was also repeated in duplicate using
untreated white filter paper (Whatman’s No. 1: GE
Healthcare Life Sciences, UK) as an additional negative
control (the randomised treated mesh sections already
contain an untreated mesh as a primary negative control).
The resulting 24 pots containing ‘exposed’ Culicoides
were then incubated at 27 °C (+/− 2 °C) and 70 %rH
(+/−5 %) for 24 h in an incubator (model 303NP: LMS
Ltd, UK) with additional humidity supplied via a Vicks
Mini Ultra Humidifier (model: VH5000E1; Proctor &
Gamble, UK). In order to allow blood feeding responses to
be tested post-incubation, the exposed Culicoides were
not given access to sucrose solution during the incubation
period. Following the 24 h incubation, pots containing the
‘exposed’ Culicoides were removed from the incubator
and the number of live (capable of oriented movement)
and dead (motionless) Culicoides in each pot were
recorded. To record sub-lethal anti-feedant effects of
exposure, each pot containing at least one live Culicoides
was given access for one hour to defibrinated horse blood
(TCS Biosciences, UK) supplied and warmed to 37 °C via
a Hemotek Membrane Feeding System (Hemotek, UK)
with stretched Parafilm M® membrane (Bemis Company
Inc., WI, USA). Following the one hour feeding period all
Culicoides were killed by prolonged exposure to cold
(−20 °C), the contents of each pot were then examined
under a stereomicroscope (x4-40 magnification) and the
number of fed and unfed Culicoides recorded. The
temperature (°C) and relative humidity (% rH) during the
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monitored and recorded using TinyTag View 2 data
loggers (Gemini Data Loggers Ltd, UK).
The above treatment protocol and cone bioassay
protocol was repeated in triplicate to account for vari-
ation in colony Culicoides batch, weather conditions or
treatment application. This resulted in a total of three
mesh sections/filter paper controls for each treatment
or control (hereafter referred to as the ‘treatment
batches’) with two bioassay cones for each mesh section
or filter paper control (within-mesh section replicates),
with 25 C. nubeculosus per bioassay cone, resulting in a
total of 150 C. nubeculosus being exposed in each treat-
ment or control.
Statistical analysis
Generalised Linear Mixed Models (GLMM) with a
Binomial error distribution and a logit link function
were implemented in a Bayesian setting using the
bglmer function in package ‘blme’ version 1.0-2 [37] in
R v 3.1.2 [38] in order to investigate the effect of treatment
on C. nubeculosus mortality and feeding rate. The GLMMs
were fitted by maximum likelihood with the Laplace
approximation with flat covariance priors and normal fixed
priors, with product and days since treatment considered as
fixed effects and treatment batch and within-mesh section
replicate as nested random effects to take into account any
variation between batches and replicates not accounted for
by the fixed effects. In models of C. nubeculosus feeding
rate, mortality rate was also included as a fixed effect to
account for variation in the number of surviving Culicoides
present able to potentially feed. Final models were obtained
using a backwards-stepwise-selection-based procedure [39],
such that variables that did not contribute significantly to
explaining variation in mortality rate or feeding rate were
successively eliminated on the basis of Akaike Information
Criterion (AIC) [40]. This continued until the removal of
a variable caused an increase in AIC of two or more.
Differences in mortality rates and feeding rate between
treatments were then assessed using multiple Tukey’s
all-pair comparisons using the ‘glht’ function in package
multcomp version 1.3-7 [41].
Field trials
A treatment was selected on the basis of causing the
highest mortality rate and/or greatest reduction in feeding
rate during the modified WHO bioassays. In order to
assess the efficacy of this treatment under field conditions,
two sets of experiments were conducted at a polo club in
Hampshire, UK (51.2414° N, −1.6645° W) between June
and August 2014. This location was selected with prior
knowledge of a large number of horses being present exhi-
biting clinical signs of summer seasonal recurrent allergic
dermatitis. Weather conditions (air temperature (°C),relative humidity (%), rainfall (mm), wind speed (ms−1),
wind direction (°), and solar radiation (wm-2)) during all
field trials were recorded every 15 min, using an automatic
weather station (Decagon Devices, Pullman, WA, USA),
and summarized as mean values across each overnight
trapping period. Wind direction is a circular variable, with
the constraint that directions of 0°and 360° represent the
same direction. Hence the mean transformed wind direc-
tion for each trapping period was calculated using the
mean angle trigonometric such that transformed wind
direction =ATAN2(sin(wind direction), cos(wind direc-
tion)) ∗ (180/π)).
Field trial one
The first field trial utilised a randomised Latin square
design to assess the effectiveness of insecticide-treated nets
to prevent Culicoides entry under field conditions over an
extended time period. Ultraviolet (UV) Center for Disease
Control (CDC) light-suction traps (model 912: John W
Hock, FL, USA) were hung within three open-sided
wooded frames (width: 1.0 m; length: 1.0 m; height: 1.2 m),
with solid black roofs extending 10 cm in each direction,
and solid white wooden bases (one trap per frame) (Fig. 3).
The sides of each frame were either: (i) covered with
insecticide-treated mesh, (ii) covered with untreated mesh,
or (iii) left uncovered without mesh (Fig. 3). Mesh panels
were secured to the wooden frame using 2 cm wide stick-
on Velcro® (RS Components, Corby, UK), in addition to the
adhesive glue on the Velcro®, each strip was sewed onto the
mesh panels with black cotton thread to increase adhesion.
Mesh panels were treated using a 1.5 L hand-held pump
sprayer (Pest Control Shop, Preston, UK) on day 0 and
attached to the wooden frames. Untreated mesh panels
were also attached to the wooden frames on day 0.
Overnight collections using the UV CDC traps in each of
the three frames were then made on day 1, 3, 5, 7, 9, 11, 13
and 15. Insects were collected into water with a drop of
non-bleaching detergent (Hederol: Proctor and Gamble
Professional, UK), then transferred to 70 % ethanol for
storage prior to identification. Any Culicoides which had
passed through the mesh, but had not been collected in
the light-trap were aspirated from the base of the wooden
frame using a battery powered aspirator (Watkins and
Doncaster, UK) and stored in 70 % ethanol prior to identi-
fication. The above procedure was repeated in triplicate
resulting in 24 overnight collections for each treatment
(eight per treatment batch) and 72 collections in total.
Frames were rotated between trap locations with their
treatments to prevent any potential cross-contamination,
and placed at least 50 m apart.
Field trial two
The second field trial utilised a three by three randomised
Latin square design. Ultraviolet CDC light-suction traps
Fig. 3 Field Trial One: Equipment utilised to investigate the effectiveness of insecticide-treated mesh in preventing entry of Culicoides. Ultraviolet
(UV) Center for Disease Control (CDC) light-suction trap (model 912: John W Hock, FL, USA) hung within an open-sided wooded frame (width:
1.0 m; length: 1.0 m; height: 1.2 m), with solid black roofs extending 10 cm in each direction, and solid white wooden base. The sides of each
frame were either: (i) covered with insecticide-treated mesh, (ii) covered with untreated mesh, or (iii) left uncovered without mesh
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hung within three stables on the stable yard, one trap per
stable. The entrance to each stable was then either (i)
covered with insecticide-treated mesh, (ii) covered with
untreated mesh, or (iii) left uncovered without mesh
(Fig. 4). Mesh panels were secured to the stable doors
using 5 cm wide heavy-duty stick-on Velcro®(Velcro Ltd,
Middlewich, UK) and each strip was sewed onto the mesh
panels with black cotton thread to increase adhesion.
Mesh panels were treated using a 1.5 L hand-held pump
sprayer (Pest Control Shop, Preston, UK) on day 0 and
attached to the stable doors. Untreated mesh panels were
also attached to the stable doors on day 0. Overnight
collections using the UV CDC traps in each of the three
stables were then made on day 1, 2 and 3. Insects were
collected into water with a drop of non-bleaching detergent
(Hederol: Proctor and Gamble Professional, UK) then
transferred to 70 % ethanol for storage prior to identifica-
tion. Nine overnight collections were carried out for eachFig. 4 Field Trial Two: Stable type utilised in field trial two to investigate th
Culicoides as measured by miniature Ultraviolet (UV) Center for Disease Con
within each stable whose entrance was either (i) covered with insecticide-t
without meshtreatment and 27 in total. Each stable contained one horse
and doors were not opened while the UV light-traps were
operational, with the horses present within the stables for
the duration of the overnight collection periods. Horses
were not rotated with treatments ensuring each treatment
was tested with each horse/stable combination three times
in a cross-over design allowing any inter-horse variation in
their attractiveness to Culicoides to be accounted for in the
statistical analysis.
Culicoides species identification
Culicoides were separated from other arthropods using a
stereo microscope (10-40X) and then further identified
to species-level based on wing morphology [42]. Female
specimens of the subgenus Avaritia species were identified
to group level morphologically and then identified to
species level using a multiplex polymerase chain reaction
(PCR) assay [43]. Total DNA was extracted from individ-
ual Culicoides specimens using a non-destructive DNAe effectiveness of insecticide-treated mesh in preventing entry of
trol (CDC) light-suction traps. One UV light-suction trap was located
reated mesh, (ii) covered with untreated mesh, or (iii) left uncovered
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incubated in 200 μl of DXT Tissue Digest Reagent
(Qiagen, Crawley, UK) with 1 % Proteinase K (Qiagen,
Crawley, UK) for 16 h at 40 °C. Culicoides were then
transferred individually from the tissue digest solution
to 70 % ethanol and stored at 4 °C for future analysis.
The remaining tissue digest solution was then incubated
at 70 °C for 15 min to inactivate the proteinase K and then
ethanol precipitated to remove PCR inhibitors using either
Pellet Paint® Co-Precipitant (Merck Millipore, Darmstadt,
Germany) or glycogen from Mytilus edulis (Roche, UK) as
a co-precipitant to improve DNA yield. The purified DNA
extractions were resuspended in 100 μl of 10 mM Tris
HCL pH 8.0 (Buffer EB: Qiagen, Crawley, UK).
PCR amplification was conducted in a GeneAmp
9700 thermal cycler (Applied Biosystems, UK). Reac-
tions were performed in a total of 12 μl consisting of
0.4 μl nuclease free water, 6.0 μl TopTaq mastermix
(Qiagen, UK), 1.2 μl CoralLoad concentrate (Qiagen,
UK), 1.2 μl D- (+)-Trehalose, 0.2 μl 20 mM C. obsoletus
specific forward primers, (obsF 5′ TGCAGGAGCTTCTG-
TAGATTTG 3′) [45], 0.4 μl 20 mM C. scoticus specific for-
ward primer (ScoF 5′ ACCGGCATAACTTTTGATCG 3′)
[45], 0.2 μl 20 mM C. chiopterus specific forward primer
(ChiF 5′ TACCGCCCTCTTATCACCCTA 3′) [45], 0.2 μl
20 mM C. dewulfi specific primer (DewF 5′ ATACTAG-
GAGCGCCCGACAT 3′) [45], and 1.0 μl 20 mM Culi-
coides universal reverse primer COIR (5′ CAGGTAAAAT
TAAAATATAAACTTCTGG 3′) [43] and 2 μl DNA tem-
plate. Positive and negative controls for the amplification
reactions were carried out at every PCR round. The PCR
cycling conditions were as follows: an initial denaturation
step at 94 °C for 3 min followed by 35 cycles of 94 °C for
30 s, 58 °C for 30 s, 72 °C for 1 min, followed by a final
extension step at 72 °C for 10 min. Amplification was
assessed by electrophoresis of PCR products on 2 % (w/v)
pre-cast agrose gels containing SYBR Safe (E-Gel® 96: Life
Technologies, UK) run for seven minutes. Gels were
visualised and imaged using Chemi-Doc MP system
(BioRad, UK). E-gel® images were then edited using the E-
editor system (Life Technologies, UK), and banding
patterns compared to each other along with positive
controls, and by comparison with E-Gel® Low Range
Quantitative DNA Ladder (100–2000 bp:Life Technologies,
UK) to allow species composition based on the following
expected band sizes: C. obsoletus 355 bp; C. scoticus:
229 bp; C. dewulfi: 493 bp; C. chiopterus: 435 bp.
Statistical analysis
Generalised Linear Mixed Models (GLMM) with a
Binomial error distribution and a logit link function
were implemented in a Bayesian setting using the
bglmer function in package ‘blme’ version 1.0-2 [37] in
R v 3.1.2 [38] in order to investigate the effect oftreatment on the number of Culicoides and specifically
the number of females of potential AHSV vector spe-
cies of Culicoides (C. obsoletus; C. scoticus; C. dewulfi;
C. chiopterus) collected within UV CDC light-suction
traps inside frames (field trial one) or inside stables
(field trial two) which are either: (i) covered with
insecticide-treated mesh, (ii) covered with untreated
mesh, or (iii) left uncovered, i.e. no mesh (Fig. 5). The
GLMMs were fitted by maximum likelihood with the
Laplace approximation with flat covariance priors and
normal fixed priors, with treatment batch included as
a random effect treatment, trap location, days post-
treatment and meteorological conditions comprising a
total of five predictors considered as additional fixed
predicators. Meteorological predictors were: mean air
temperature (°C), mean humidity (% rH), precipitation
(mm), mean solar radiation (wm−2), mean wind speed
(m/s), mean transformed wind direction (°) as linear
functions. Final models were obtained using a backwards-
stepwise-selection-based procedure [39], such that variables
that did not contribute significantly to explaining variation
in trap catch were successively eliminated on the basis of
AIC [40]. This continued until the removal of a variable
caused an increase in AIC of two or more. Differences in
trap catch size between covering treatments were then
assessed using multiple Tukey’s all-pair comparisons using
the ‘glht’ function in package multcomp version 1.3-7 [41].
In addition, for each treatment in field trial one and two
the mean Coefficient of Protection from Intrusion (CPI) [46]
was calculated with CPI = ((A −B) × 100)/A where A is the
number of Culicoides collected inside the frame/stable with
no mesh i.e. the control, and B is the number trapped




Mortality observed in exposed C. nubeculosus was found
to be best described by a model including the predictors
treatment and days post-treatment as fixed effects and
treatment batch and within-mesh replicate as random
factors (Table 3). Over the two week period (sampling at
day 1, 7 and 14) there was no significant difference in
the mortality rate observed between the untreated mesh
sections (treatment K) and the filter paper controls
(treatment L) (Tables 3 and 4). Mean mortality rates of
12.2 % (range: 4–16 %) and 11.1 % (range: 0–16 %) were
observed in the untreated control mesh and the filter
paper control, respectively. Over the two week period
(sampling at day 1, 7 and 14) all insecticide/repellent-
based treatments (treatments A, B, C, D, E, F, G, H, I
and J) caused significantly greater mortality than either
the untreated control mesh and the filter paper control
(P ≤ 0.001) (Table 4). Treatment F, however, was the only
Fig. 5 World Health Organisation (WHO) Cone Bioassays: Box-and-whisker plots of percentage mortality in C. nubeculosus 24 h post-exposure and split
by treatment and days since treatment. Variation within the box-and-whisker plots represents variance in mortality rates between treatment batches and
between within-mesh section replicates. Median values shown as filled black circles, outliers as hollow black circles, the interquartile range as hollow
rectangles (black: insecticide-based treatments; green: repellent-based treatments; blue: negative controls)
Table 3 World Health Organisation (WHO) Cone Bioassays: Regression coefficients with 95 % Wald confidence intervals and ΔAIC for
the fixed effects of two final Bayesian general linear mixed models with a Binomial error distribution used to describe (i) mortality
rate and (ii) blood feeding rate of C. nubeculosus (Meigen), 1830 exposed during WHO cone bioassay tests
Parameters Mortality rate Blood feeding rate
Estimate (95 % CI) ΔAIC Estimate (95 % CI) ΔAIC
Intercept −1.35 (−1.60; −1.11)*** −0.98 (−1.63; −0.34)**
Treatment 1779.5 2243.4
Product B 0.72 (0.45;1.00)*** 0.51 (0.02;1.00)*
Product C 1.13 (0.85; 1.41)*** 1.18 (0.72; 1.64)***
Product D 0.53 (0.26; 0.81)*** 1.12 (0.64; 1.60)
Product E 0.17 (−0.11; 0.45) 0.93 (0.42; 1.43)***
Product F −5.67 (−7.74; −3.59)*** −1.99 (−5.49; 1.51)
Product G −0.54 (−0.84; −0.24)*** 1.55 (1.02; 2.08)***
Product H 1.89 (1.59; 2.19)*** 1.69 (1.24; 2.14)***
Product I 1.88 (1.58; 2.19)*** 1.48 (1.03; 1.93)***
Product J 1.64 (1.35; 1.93)*** 0.98 (0.53; 1.44)***
Product K 2.72 (2.38; 3.07)*** 2.00 (1.55; 2.46)***
Product L 2.83 (2.47; 3.19)*** 1.77 (1.32; 2.22)***
Days post-treatment 0.09 (0.08; 0.11)*** 225.6 0.22 (0.01; 0.04)** 689.5
Mortality rate - - −0.05 (−0.05; −0.04)*** 463.8
Random effects included in the final model included the effect of treatment batch and within section replicate
*** P ≤ 0.001, ** P ≤ 0.01, * P ≤ 0.05
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Table 4 World Health Organisation (WHO) Cone Bioassays: Multiple Tukey’s all-pair comparisons of mortality rate between
treatments taking into account variation caused by days since treatment, batch and replicate
Treatment A B C D E F G H I J K L
A - 0.72*** 1.13*** 0.53** 0.17 NS −5.67*** −0.54* 1.89*** 1.88*** 1.64*** 2.72*** 2.83***
B - 0.41 NS −0.19 NS −0.56** −6.39*** −1.26*** 1.17*** 1.16*** 0.92*** 2.00*** 2.11***
C - −0.60*** −0.97*** −6.80*** −1.67*** 0.76*** 0.75*** 0.50* 1.59*** 1.70***
D - −0.37 NS −6.20*** −1.07*** 1.36*** 1.35*** 1.10*** 2.19*** 2.30***
E - −5.83*** −0.71*** 1.72*** 1.71*** 1.47*** 2.56*** 2.66***
F - 5.13*** 7.56*** 7.55*** 7.30*** 8.39*** 8.50***
G - 2.43*** 2.42*** 2.18*** 3.26*** 3.37***
H - −0.01 NS −0.25 NS 0.84*** 0.94***
I - −0.24 NS 0.85*** 0.95***
J - 1.09*** 1.19***
K - 0.11 NS
L -
Estimate with P values shown as superscript (***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05)
Baker et al. Parasites & Vectors  (2015) 8:604 Page 9 of 17treatment to exhibit 100 % mortality at all three sampling
time points and for all treatment batches and within-mesh
section replicates (Fig. 5) and caused significantly greater
mortality rates than all other treatments tested (P ≤ 0.001)
(Table 4). The mortality rates were not significantly
different between the three repellent compounds tested
(Treatments H, I and J) (Table 4). The mortality rates
caused by exposure to the insecticide-based compounds
tested (Treatments A, B, C, D, E, F and G) were signifi-
cantly (P ≤ 0.001) higher than the repellent compounds
tested (Treatments H, I, J) (Table 4). Over the two weekFig. 6 World Health Organisation (WHO) Cone Bioassays: Kernel density est
across treatments and mesh section replicates, split by days since treatmen
dashed line = treatment batch 2; dotted blue line = treatment batch 3)period, mortality rates between treatment batches were
relatively consistent at one day post-treatment but variation
between treatment batches increased significantly at seven
and 14 days post-treatment (Fig. 6). During the three
minute exposure period no appreciable spatial repellence
was observed in the behaviour of exposed C. nubeculosus’
in response to any of the treatments in any of the treatment
batches or within-mesh section replicates.
Blood feeding observed in exposed C. nubeculosus was
best described by a model including the predictors’
treatment, days post-treatment and mortality rate asimation plots illustrating the variability in C. nubeculosus mortality rates
t and treatment batches (solid green line = treatment batch 1; red
Baker et al. Parasites & Vectors  (2015) 8:604 Page 10 of 17fixed effects and treatment batch and within-mesh replicate
as random factors (Table 3). Over the two week period
(sampling at day 1, 7 and 14) there was no significant
difference in the number of C. nubeculosus which
successfully obtained a bloodmeal, taking into account
the mortality rate observed between the untreated
mesh sections (treatment K) and the filter paper
controls (treatment L) (Table 5). Mean blood feeding rates
of surviving C. nubeculosus of 73.9 % (0–100.0 %) and
68.4 % (0–100.0 %) were observed in the untreated control
mesh and the filter paper control, respectively (Fig. 7).
Over the two week period (sampling at day 1, 7 and 14)
repellent treatments H and I caused no significant reduc-
tion in blood feeding rate in surviving C. nubeculosus,
though repellent-based treatment J did cause a significant
(P ≤ 0.001) decrease in the rate of blood feeding for
surviving C. nubeculosus (Table 5). Insecticide-based
treatments A, B, C, D and E all demonstrated signifi-
cant reductions in blood feeding rates in surviving C.
nubeculosus when compared to the untreated mesh
sections (treatment K) and the filter paper controls
(treatment L) (Table 5). Over the two week period,
significant variability in blood feeding rates in surviving
C. nubeculosus between treatment batches was observed
at all-time points measured (Fig. 8). Due to the superior
performance of Treatment F over all other treatments in
causing mortality in exposed C. nubeculosus, all further




Over the 24 nights of UV CDC light-suction trap collec-
tions in field trial one 161 Culicoides comprising of five
species: C. obsoletus, C. scoticus, C. dewulfi, C. chiopterusTable 5 World Health Organisation (WHO) Cone Bioassays: Multiple
ments taking into account variation caused by days since treatment
Treatment A B C D E F
A - 0.51 1.18*** 1.12*** 0.93* −1.99
B - 0.67* 0.61† 0.42 −2.50
C - −0.06 −0.26 −3.17









Estimate with P values shown as superscript (***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05)and C. brunnicans (Edwards), 1939 were collected (Table 6).
Collections were dominated by female Culicoides (97 %),
with only five male C. obsoletus collected. Of the 145 female
subgenus Avaritia Culicoides collected 52 % were identified
via multiplex PCR as C. obsoletus; 19 % as C. scoticus; 15 %
as C. dewulfi; and 8 % as C. chiopterus. The multiplex
PCR however, failed to identify 6 % of morphologically
identified subgenus Avaritia specimens. Of the total
number of Culicoides collected 94 % were collected inside
the frames with no mesh covering i.e. the control, 6 %
were collected inside the frames with untreated mesh
coverings and no Culicoides were collected within the
frames with insecticide-treated mesh coverings (Table 6).
he total number of Culicoides collected and the total
number of potential AHSV vector Culicoides collected
by the UV CDC light-suction traps inside the wooden
frames was found to be best described by a model
including the predictors’ treatment, precipitation,
windspeed, transformed wind direction, solar radiation
and days post-treatment as fixed effects and treatment
batch as a random factor (Table 7). Initial models and
multiple Tukey’s all-pair comparisons indicated the UV
CDC traps inside frames which were covered with either
the insecticide-treated mesh (treated using treatment F
see Table 1) or the untreated mesh collected significantly
(P ≤ 0.001) fewer Culicoides and significantly (P ≤ 0.001)
fewer female potential AHSV vector Culicoides than that
collected in the uncovered frames (Table 8).However, the
number of Culicoides and the number of female
potential AHSV vector Culicoides collected inside
frames which were covered with insecticide-treated
mesh compared to the untreated mesh were not
significantly different (Table 7).
The mean CPI for the untreated mesh and the
insecticide-treated mesh in comparison to the no meshTukey’s all-pair comparisons of bloodfeeding rate between treat-
, batch and replicate
G H I J K L
1.55*** 1.69*** 1.48*** 0.98** 2.00*** 1.77***
1.04*** 1.18*** 0.97*** 0.47 1.49*** 1.26***
0.37 0.51*** 0.30 −0.20 0.82*** 0.59*
0.42 0.56* 0.36 −0.14 0.88*** 0.65*
0.62 0.76** 0.55 0.06 1.08*** 0.84**
3.53 3.68 3.47 2.97 3.99 3.76
- 0.14 −0.07 −0.56 0.46 0.22
- −0.21 −0.71*** 0.31 0.08




Fig. 7 World Health Organisation (WHO) Cone Bioassays: Box-and-whisker plots of percentage of the total number of exposed C. nubeculosus which suc-
cessfully obtained a bloodmeal split by treatment and days post-treatment. Variation within the box-and-whisker plots represents variance in blood feeding
rate between treatment batches and between within-mesh section replicates. Median values shown as filled black circles, outliers as hollow black circles,
the interquartile range as hollow rectangles (black: insecticide-based treatments; green: repellent-based treatments; blue: negative controls)
Baker et al. Parasites & Vectors  (2015) 8:604 Page 11 of 17control was 88 % (range: −100 %; 100 %) and 100 %
(range: 100 %; 100 %) respectively.
Field trial two
Over the nine nights of UV CDC light-suction trap collec-
tions in field trial two, 74 Culicoides comprising of fiveFig. 8 World Health Organisation (WHO) Cone Bioassays: Kernel density est
rates across treatments and mesh section replicates, split by days since trea
red dashed line = treatment batch 2; dotted blue line = treatment batch 3)species: C. obsoletus, C. scoticus, C. dewulfi, C. chiopterus
and C. brunnicans were collected (Table 9). Collections
were again dominated by female Culicoides (99 %), with
only one male C. brunnicans collected. Of the 73
female subgenus Avaritia Culicoides collected 34 %
were identified via multiplex PCR as C. obsoletus, 47 %imation plots illustrating the variability in C. nubeculosus bloodfeeding
tment and treatment batches (solid green line = treatment batch 1;
Table 6 Field Trial One: Culicoides collected within Ultraviolet (UV) Center for Disease Control (CDC) light-suction traps which are
within frames which are either (i) covered with insecticide-treated mesh, (ii) covered with untreated mesh, or (iii) left uncovered, i.e.
















0 (0; 0) 0 (0; 0) 0 (0; 0) 0 (0; 0) 0 (0; 0) 0 (0; 0)
Untreated mesh 5 (4; 1) 1 (1; 0) 2 (2; 0) 0 (0; 0) 1 (1; 0) 1 (1; 0)
No mesh control 78 (71; 7) 27 (27; 0) 20 (20; 0) 12 (12; 0) 7 (7; 0) 7 (7; 0)
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(Table 9). The multiplex PCR however, failed to identify
7 % of morphologically identified subgenus Avaritia
specimens. Of the total Culicoides, 80 % were collected
inside the stables with no mesh protection, 16 % were
collected inside the stables with untreated mesh protec-
tion and 4 % were collected within the stables with
insecticide-treated mesh protection (Table 9).
Both the total number of Culicoides collected and the
total number of subgenus Avaritia individuals collected
within the stables was found to be best described by a
model including treatment and windspeed as fixed effects
and treatment batch as a random factor (Table 10). Initial
models and multiple Tukey’s all-pair comparisons indicated
the UV CDC trap inside stables whose entrances were
covered with either the insecticide-treated mesh (treated
using treatment F see Table 1) or the untreated mesh
collected significantly (P ≤ 0.001) fewer Culicoides and
significantly (P ≤ 0.001) fewer subgenus Avaritia individuals
than that collected in the uncovered control stable
(Table 11). However, the number of Culicoides and the
number of subgenus Avaritia collected inside stables whoseTable 7 Field trial one: Regression coefficients with 95 % Wald confid
general linear mixed models with a Poisson error distribution used to
(ii) the number of females of potential AHSV vector species of Culicoid
and Kettle, 1952; Culicoides dewulfi (Goetghebuer), 1936; and Culicoides
Disease Control (CDC) light-suction traps within frames either (i) cover
or (iii) left uncovered
Parameters Total Culicoides collected
Estimate (95 % CI) Δ
Intercept 2.322 (1.79; 2.86)***
Treatment 2
Insecticide-treated mesh −5.19 (−7.37; −3.01)***
Untreated mesh −2.65 (−3.28; 2.02)***
Precipitation −3.30 (−6.11: −0.49)* 5
Windspeed −1.35 (−2.38; −0.32)* 4
Transformed wind direction −0.10 (−0.12: −0.32)*** 1
Solar radiation 0.02 (0.00, 0.03)** 3
Days post-treatment −0.11 (−0.015; −0.06)*** 1
Random effects included in the final model included the effect of treatment batch
*** P ≤ 0.001, ** P ≤ 0.01, * P ≤ 0.05entrances were covered with insecticide-treated mesh in
comparison to the untreated mesh were not significantly
different (Table 7).
The mean CPI for the untreated mesh and the
insecticide-treated mesh in comparison to the no mesh
control was 71 % (range: 0 %; 100 %) and 96 % (range:
78 %; 96 %) respectively. Meteorological conditions re-
corded during field trial one and two are shown in Table
12.
Discussion
This study is the first to utilise WHO cone bioassays to
investigate the mortality rate in Culicoides caused by
exposure to insecticide treated nets (ITNs). In addition,
the study is also the first to investigate the effectiveness
and logistical feasibility of utilising ITNs to protect
horses from Culicoides in the UK using field experiments.
A pyrethroid-based insecticide which is currently licenced
for use by amateurs and commercially available ready-
formulated on the UK market (treatment F: Tri-Tec 14®
(LS Sales (Farnham) Ltd, UK)) was found to cause 100 %
mortality in exposed Culicoides for up to two weeks post-ence intervals and ΔAIC for the fixed effects of two final Bayesian
describe (i) the total number Culicoides collected (all species) and
es (Culicoides obsoletus (Meigen), 1818; Culicoides scoticus Downes
chiopterus (Meigen), 1830) collected in Ultraviolet (UV) Center for
ed with insecticide-treated mesh, (ii) covered with untreated mesh,
Total female potential AHSV vectors Culicoides





.6 −3.30 (−6.11; −0.50)* 5.6
.1 −1.35 (−2.38; −0.32)* 4.1
16.7 −0.10 (−0.12; −0.08)*** 116.7
.4 0.02 (0.00; 0.03)** 3.4
6.7 −0.11 (−0.15; −0.06)*** 16.7
Table 8 Field trial one: Multiple Tukey’s all-pair comparisons of (i) the total number Culicoides collected (all species) and (ii) the number
of females of potential AHSV vector species of Culicoides (Culicoides obsoletus (Meigen), 1818; Culicoides scoticus Downes and Kettle, 1952;
Culicoides dewulfi (Goetghebuer), 1936; and Culicoides chiopterus (Meigen), 1830) collected within Ultraviolet (UV) Center for Disease Con-
trol (CDC) light-suction traps within frames which are either (i) covered with insecticide-treated mesh, (ii) covered with untreated mesh,
or (iii) left uncovered
Insecticide-treated mesh Untreated mesh No mesh
Total Culicoides (all species) Insecticide-Treated Mesh - −2.54 NS −5.19***
Untreated Mesh - - −2.65***
No Mesh - - -
Total female potential AHSV vector Culicoides Insecticide-Treated Mesh - −2.54 NS −2.65***
Untreated Mesh - - −2.65***
No Mesh - - -
NS not significant
Estimate with P values shown as superscript *** P ≤ 0.001
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untreated-mesh and mesh treated with the insecticide Tri-
Tec 14® were found to significantly reduce the entry of
Culicoides both into frames covered with mesh and to
stables whose entrance had been covered with mesh.
These results provide strong quantitative evidence that this
relatively straightforward measure can have a significant
impact on reducing Culicoides-horse contact and therefore
at least provide a substantial degree of mitigation against
AHSV transmission.
In addition to testing insecticidal compounds, this study
also examined the impact of repellents on C. nubeculosus
survival following exposure. Repellent-based compounds
are commonly used by horse-owners in attempts to reduce
biting rates on horses, both during grazing and while being
ridden. It is therefore likely that at least a proportion of
owners might treat mesh netting with these same products
to reduce the impact of equine summer seasonal recurrent
allergic dermatitis or in the event of an outbreak of AHSV.
While, as expected, the three repellent-based products
tested were not found to cause any significant levels of
mortality in C. nubeculosus following exposure, the
Citradiol-based repellent (Treatment J: NAF Off Extra
Effect (Greencoat Ltd, UK)) did appear to result in a
significant anti-feeding response in exposed Culicoides
at 1, 7 and 14 days post-treatment of the mesh netting,
which is worthy of further investigation.Table 9 Field Trial two: Culicoides collected within Ultraviolet (UV) C










0 (0; 0) 1 (1; 0) 0 (0; 0)
Untreated mesh 5 (5; 0) 5 (5; 0) 0 (0; 0)
No mesh control 20 (20; 0) 28 (28; 0) 4 (4; 0)
Total number collected with the number of female; male shown in parenthesisThe use of untreated mesh to screen stables has
previously been shown to provide a degree of protec-
tion to equines from Culicoides [20, 47, 48]. The use of
synthetic pyrethroids to further enhance the protection
provided by screening for equines was supported by this
study reinforcing the findings of Pages et al. [49, 50]. How-
ever, the results of this study highlight the significant vari-
ation in performance among those formulations licensed
for amateur use. All insecticide-based treatments tested
within this study contained either cypermethrin,
pyrethrins, permethrin, tetramethrin or a combination of
these compounds. While within this study there was no
clear order of effectiveness in causing mortality and/or
anti-feedant effect between the treatments according to
what pyrethroid type they contained, systematic compari-
son of active ingredients would assist product development.
An obvious omission to the above list is any insecticide
based on deltamethrin, which has demonstrated high
toxicity to C. obsoletus in Spain and France in laboratory
exposure assays to treated filter papers [51, 52], but is not
currently available in the UK in a formulation available for
amateur use. Robin et al. [53], however, found ‘off-label’
topical application of 1 % deltamethrin did not significantly
reducing biting rates on horses. The treatment identified as
causing the highest mortality in the WHO cone bioassay
tests (treatment F: Tri-Tec 14® (LS Sales (Farnham) Ltd,
UK)) did have the highest concentration of cypermethrinenter for Disease Control (CDC) light-suction traps within stables









1 (1; 0) 1 (1; 0) 0 (0; 0)
1 (1; 0) 1 (1; 0) 0 (0; 0)
3 (3; 0) 3 (3; 0) 1 (1; 0)
Table 10 Field trial two: Regression coefficients with 95 % Wald confidence intervals and ΔAIC for the fixed effects of two final Bayesian
general linear mixed models with a Poisson error distribution. The model was used to describe (i) the total number Culicoides collected
(all species) and (ii) the number of females of potential AHSV vector species of Culicoides (Culicoides obsoletus (Meigen), 1818; Culicoides
scoticus Downes and Kettle, 1952; Culicoides dewulfi (Goetghebuer), 1936; and Culicoides chiopterus (Meigen), 1830) collected within
Ultraviolet (UV) Center for Disease Control (CDC) light-suction traps within stables whose entrances are either (i) covered with
insecticide-treated mesh, (ii) covered with untreated mesh, or (iii) left uncovered
Parameters Total Culicoides collected Total female potential AHSV vector Culicoides
Estimate (95 % CI) ΔAIC Estimate (95 % CI) ΔAIC
Intercept 4.13 (2.91; 5.35)*** 4.27 (2.91; 5.35)***
Treatment 68.7 68.9
Insecticide-treated mesh −2.83 (−3.91; −1.74)*** −2.81 (−3.91; −1.74)***
Untreated mesh −1.56 (−2.18; −0.94)*** −1.54 (−2.18; −0.94)***
Windspeed −0.06 (−0.09; −0.04)*** 62.9 −0.07 (−0.09; −0.04)*** 63.08
Random effects included in the final model included the effect of treatment batch
*** P ≤ 0.001
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based formulations tested, this is however a significantly
lower concentration than the 5.93 % w/w alphacypermethin
treatment tested by Pages et al. [49, 50]. Further dose-
dependent investigations into the sub-lethal effects of ex-
posure to cypermethrin and other pyrethroid types on both
feeding response and host-location are required, as have
previously been conducted to investigate dose-dependent
mortality rates in Culicoides [51, 54].
The manufacturers recommended re-spray period for
Tri-Tec 14® is 14 days and environmentally exposed mesh
netting was found to still be 100 % effective in killing C.
nubeculosus at this time. A respray interval of two weeks is
likely to be both logistically feasible and financially viable;
however, the ability for stables entrances to be covered
effectively is likely to vary widely due to variations in stable
design between and within yards. The apparent reduction
in the level of protection provided in field trial one com-
pared to field trial two by the untreated mesh (CPI:87.9 and
70.95 % respectively) and the insecticide-treated mesh (CPI:
100 and 96.3 %) are likely due to the increased logistical
difficulties in covering all entrance gaps to the stable con-
sistently and the small proportion of Culicoides exhibitingTable 11 Field trial two: Multiple Tukey’s all-pair comparisons of (i) t
number of female potential AHSV vector species of Culicoides (Culico
Kettle, 1952; Culicoides dewulfi (Goetghebuer), 1936; and Culicoides ch
for Disease Control (CDC) light-suction traps which are within stable
mesh, (ii) covered with untreated mesh, or (iii) left uncovered, i.e. no
Total Culicoides Insecticide-Treated Mesh
Untreated Mesh
No Mesh Control
Total female potential AHSV vector Culicoides Insecticide-Treated Mesh
Untreated Mesh
No Mesh Control
*** P ≤ 0.001diurnal activity. Nonetheless, the reduction of Culicoides
collected within the insecticide-treated net screened stable
to a single individual in the second field trial is similar to
results in RSA [20] and illustrates the value of this tech-
nique in mitigation.
Porter [55] found that while Culicoides can pass through
untreated insect screens with mesh sizes of 1.6 mm2 they
did reduce Culicoides entry rates by 56 %. The use of
smaller aperture mesh to that used in this study may have
an increased ability to exclude Culicoides from an area by
acting as a physical barrier i.e. the mesh aperture is too
small for the Culicoides to pass through. The use of such
fine mesh is, however, also associated with a significant
reduction in airflow through stables which has previously
been found to have a detrimental effect on the welfare and
respiratory performance of horses (reviewed by [56]), a
particular concern regarding high-performance competi-
tion horses. The selection of a net with a moderately large
aperture in this study allows the detrimental effects on
airflow to be minimised while still reducing Culicoides
entry rates. The contact insecticidal effect of using treated
netting provides a second line of defence with the quick
and effective knockdown provided by the Tri-Tec 14®he total number Culicoides collected (all species) and (ii) the total
ides obsoletus (Meigen), 1818; Culicoides scoticus Downes and
iopterus (Meigen), 1830) collected within Ultraviolet (UV) Center
s whose entrances are either (i) covered with insecticide-treated
mesh







Table 12 Meteorological conditions recorded during field trial
one and two. Mean with range shown in parenthesis
Variable Field trial one Field trial two
Air temperature (°C) 24.9 (10.2–19.6) 17.5 (14.4–20.3)
Relative humidity (%) 87.7 (73.1–99.5) 81.9 (75.0–89.0)
Rainfall (mm) 0.0 (0.0–0.3) 0.0 (0.0–0.2)
Wind speed (ms−1) 0.4 (0.2–1.3) 0.5 (0.3–0.9)
Solar radiation (wm-2) 11.2 (3.4–93.2) 54.0 (24.4–75.4)
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Culicoides that are able to pass through the netting.
Braverman et al. [57] are the only study to have pre-
viously investigated the efficacy of netting treated with
Tri-Tec 14®. In contrast to the findings of this study Tri-
Tec 14® treated netting was found to only significantly
reduce collections in Israel of C. imicola for between two to
five hours post-treatment (applied at 0.008 g/m2) in com-
parison to untreated net. This earlier study, however, uti-
lized an uncoated polyester type net (aperture 1.3 mm), in
comparison to the polyvinyl-coated polyester mesh
(1.6 mm aperture) used in the present study. Further
investigation is required to evaluate the level and duration
of effect of the Tri-Tec 14® treatment between different
net materials, for different vector species and in different
climates. A key consideration is the degree to which net
aperture impacts upon air circulation and dust collection
on the net which has the potential to inhibit the insecti-
cide’s performance [18]. In addition, while there has
been limited investigation into the presence of insecti-
cidal resistance in Culicoides this phenomenon is well
documented in other vector groups and further investi-
gation is required into the mechanisms underlying the
development of resistance in Culicoides and how this
varies both between species and at a population level.
ZeroFly® (Vestergaard Frandsen, Lausanne, Switzerland)
is an insect screen material available pre-treated with
deltamethrin, and is used for large biting fly control in
Africa and Asia. While it is not currently commercial avail-
able in Europe preliminary, trials in Europe with Culicoides
indicate that this type of net may be a potential alternative
to stakeholders treating nets themselves. Further studies to
compare ZeroFly®’s effectiveness and duration of activity
with the Tri-Tec 14® treated mesh net combination tested
in this study, would significantly inform outbreak response
strategies.
While species of Culicoides are considered to be the prin-
cipal vector of AHSV [7], large-scale infection studies using
horses did demonstrate that transmission by other vectors
including mosquitoes is possible however, this is likely to be
a rare event (reviewed by [58]). Further research is needed
to examine the vector competence and more widely the
vector capacity of Palaearctic Culicoides species for AHSVin addition to the potential role of other Palaearctic
hematophagous arthropods in AHSV transmission. If other
hematophagous arthropods are found to be epidemiologi-
cally significant vectors of AHSV their activity and response
to vector control measures e.g. insecticide resistance must
also be a considered as part of an integrative vector control
program in the event of an AHSV outbreak.
The infection of a susceptible uninfected host when fed
on by an infected Culicoides is a highly efficient process,
however, multiple barriers to infection are present in the
opposing process of the infection of an uninfected vector
which feeds on an infected host (reviewed by [59]). There-
fore, while the prevention of the infection of an individual
animal may require the complete prevention of Culicoides
biting to prevent infection, a vector control measure
which is significantly less effective at preventing biting my
still have epidemiologically significant effect on the rate of
transmission of AHSV. While logistically difficult to quan-
tify in a field situation efforts to estimate the community
level and cumulative effects of different vector control
measures on the outcome of AHSV outbreaks e.g. the rate
of spread, are an important consideration when planning
outbreak response policies.
Conclusions
This study has shown that ITNs have the potential to
offer protection to horses from Culicoides in the event
of an AHSV epidemic, during international movement
through endemic regions for competition and racing,
and in reducing biting nuisance. This study has, however,
demonstrated that there is significant variation in the effect-
iveness of different commercially available insecticide-based
treatments when used to treat mesh and that insecticides
providing 100 % mortality in WHO cone bioassay tests do
not necessarily provide complete prevention of ingression
in a field environment. Vector-protected accommodation
created using ITNs can be utilised as part of an integrated
control program, perhaps in combination with regular
applications of topical repellents and insecticide treat-
ment within stables. While the numbers of Culicoides
collected in this study is consistent with that collected at
other equine sites in the UK (Harrup, unpublished data),
further investigation of the effectiveness of ITNs for
preventing ingress of Culicoides to equine accommodation
at high abundance field sites e.g. those where horses and
cattle are co-located, would be very insightful; in addition,
to investigations into the effectiveness of commercially
available topical repellents and/or insecticides in reducing
equine-vector contact rates. While challenging to perform,
studies investigating if any reduction in vector-host
contact caused by ITN usage in AHSV hyper-endemic
regions could significantly reduce infection rates would
be invaluable when considering the limitations of such
control measures [1, 60].
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